Back to search
FDAFDA · Food and drugs·Recall number D-059-2013

Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05

Published November 28, 2012 · Recall initiated: September 27, 2012

Summary

FDA records drug Class II recall D-059-2013, published November 28, 2012 and initiated September 27, 2012. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 1512 bottles; Lot: Lot C203090 Exp.03/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide. No foreign consignees.
Lot
Lot C203090 Exp.03/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05 recalled?

Yes. FDA published recall D-059-2013 on November 28, 2012. Reported hazard: Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter